Elizabeth Masson Hurlburt Cor Medix Inc. (CRMD) insider trading activity

Elizabeth Masson Hurlburt is Chief Operating Officer of CorMedix Inc.. Currently has a direct ownership of 166,095 shares of CRMD, which is worth approximately $1.88 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 10,895 shares (Common Stock) at a price of $12.16 per share, resulting in proceeds of $132,483. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K

6.16% 3M change

43.52% 12M change

Total Value Held $1.88 Million

Elizabeth Masson-Hurlburt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Payment of exercise price or tax liability	$132,483 $12.16 p/Share	10,895 Reduced 6.16%	166,095 Common Stock
Sep 11 2025	SELL Open market or private sale	$537,862 $13.08 p/Share	41,121 Reduced 18.85%	176,990 Common Stock
Sep 11 2025	BUY Exercise of conversion of derivative security	$59,625 $1.45 p/Share	41,121 Added 15.86%	218,111 Common Stock
Sep 09 2025	SELL Open market or private sale	$173,954 $13.51 p/Share	12,876 Reduced 6.78%	176,990 Common Stock
Sep 09 2025	BUY Exercise of conversion of derivative security	$18,670 $1.45 p/Share	12,876 Added 6.35%	189,866 Common Stock
Aug 29 2025	BUY Grant, award, or other acquisition	-	69,686 Added 27.32%	185,414 Common Stock
Jan 10 2025	SELL Payment of exercise price or tax liability	$64,790 $11.19 p/Share	5,790 Reduced 4.76%	115,728 Common Stock

Jan 02 2025	SELL Payment of exercise price or tax liability	$93,527 $8.22 p/Share	11,378 Reduced 8.56%	121,519 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	87,500 Added 39.7%	132,897 Common Stock
Nov 14 2024	SELL Open market or private sale	$1,565,501 $11.18 p/Share	140,027 Reduced 75.52%	45,397 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$638,523 $4.56 p/Share	140,027 Added 43.03%	185,424 Common Stock
Jan 12 2024	SELL Payment of exercise price or tax liability	$15,972 $3.47 p/Share	4,603 Reduced 7.94%	53,397 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	50,000 Added 46.3%	58,000 Common Stock
May 21 2021	SELL Open market or private sale	$55,360 $6.92 p/Share	8,000 Reduced 100.0%	0 Common Stock

Elizabeth Masson Hurlburt

Chief Operating Officer

Berkeley Heights, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRMD shares.

Notify only if

Value

Insider Trading

Get notified when an Cor Medix Inc. insider buys or sells CRMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to CorMedix Inc.

Track Activities on CRMD

Account